medigraphic.com
ISSN 0016-3813 (Print)

2007, Number 2

<< Back Next >>

Gac Med Mex 2007; 143 (2)

Dopaje genético: transferencia génica y su posible detección molecular

Argüellesa CF, Hernández-Zamora E

Language: Spanish
References: 19
Page: 169-172
PDF size: 78.57 Kb.


ABSTRACT

The use of illegal substances in sports to enhance athletic performance during competition has caused international sports organizations such as the COI and WADA to take anti doping measures. A new doping method know as gene doping is defined as “the nontherapeutic use of genes, genetic elements and/or cells that have the capacity to enhance athletic performance”. However, gene doping in sports is not easily identified and can cause serious consequences. Molecular biology techniques are needed in order to distinguish the difference between a “normal” and an “altered” genome. Further, we need to develop new analytic methods and biological molecular techniques in anti-doping laboratories, and design programs that avoid the non therapeutic use of genes.


REFERENCES

  1. Hincal AA, Dalkara S. Anti-doping education and legal aspects of doping control. Regional AENOC Course. 1991 May 1-3; Ankara http://www.wilhelmgym.de/html/sport/doping/wako.htm

  2. World Anti-Doping Agency (WADA). Conference sheds light on the potential of gene doping. Conference on Gene Doping; 2002 Mar 20; New York., http://www.wilhelm-gym.de/html/sport/doping/wako.htm

  3. Código Mundial Antidopaje, versión 3, 20 de febrero de 2003 http://www.wadaama.org/en

  4. Código Mundial Antidopaje, 2004. http://www.wada-ama.org/en

  5. Unal M, Ozer Unal D. Gene doping in sport. Sports Med. 2004; 34(6):357-362.

  6. Farnaz K. Prospect of gene doping in sport to be explored by leading scientists and sports officials. WADA press room, Mar 15, 2002 (online). Available from URL: http://www.wada-ama.org

  7. Friedmann T, Koss JO. Gene transfer and athletics- an impending problem. Mol Ther 2001;3:819-820.

  8. Sherling P. Gene doping, ISM/UCL conference on Genes in Sport; 2001 Nov. 30 (online). Available from URL: http://www.archway.ac.uk/activities/departament/ SHHP/currens/dfrugs-gene.htm

  9. Melman A. Gene transfer for the therapy of erectile dysfunction: progress in the 21st century. Int J Impot Res 2006;18:19-25.

  10. Lee SJ, McPherron AC. Myostatin and the control of skeletal muscle mass. Curr Opin Gene Dev 1999;9:604-607.

  11. Engel LW. The Human Genome Project. History, goals, and progress to date. Arch Pathol Lab Med 1993;117:459-465.

  12. Roberts L, Davenport RJ, Pennisi E, Marshall E. A history of the Human Genome Project. Science 2001;291:1195.

  13. Rogers J. The finished genome sequence of Homo sapiens. Cold Spring Harb Symp Quant Biol 2003; 68:1-11.

  14. Chiche J.D. Cariou A, Mira JP. Bench-to-bedside review: Fulfilling promises of the Human Genome Project. Crit Care 2002;6:212-215.

  15. DiCecco J. Gene Doping: Creating the super-athlete Biomedical seminar I; 2002 Feb 25 (online) Available from URL: http://www.ele.uri.edu/courses/ ele282/S02/JohnD_1.pdf

  16. Unal M, Unal Ozer D. Doping Kullaniminin tarihcesi. Med Bull Istanbul Med Fac 2003;66:165.

  17. Azzazy HM, Mansour MM. Christenson RH. Doping in the recombinant era: Strategies and counterstrategies. Clin. Biochem 2005;38:959-965.

  18. Lippi G, Guidi GC. Gene manipulation and improvement of athletic performances: new strategies in blood doping. Br J Sports Med 2004;38:641.

  19. McCrory P. Super athletes or gene cheats?. Br J Sports Med 2003;37:192-193.




2020     |     www.medigraphic.com